Chidamide increases the sensitivity of refractory or relapsed acute myeloid leukemia cells to anthracyclines via regulation of the HDAC3 -AKT-P21-CDK2 signaling pathway - Concepedia

Concepedia

Publication | Open Access

Chidamide increases the sensitivity of refractory or relapsed acute myeloid leukemia cells to anthracyclines via regulation of the HDAC3 -AKT-P21-CDK2 signaling pathway

DOI Full Paper Access

56

Citations

37

References

2020

Year

Hao Wang, Yu-chen Liu, Cheng-ying Zhu, Fei Yan, Meng-zhen Wang, Xiaosu Chen, Xiao-kai Wang, Baoxu Pang, Yong-hui Li, Dai-Hong Liu,

Journal of Experimental & Clinical Cancer Research

References

	Year	Citations

Page 1